關於我們

What is this? 這是什麼？

A living collection of news and commentaries in Integrative Medicine, from policies, research, to personal health with updates on conferences, global projects and professional associations.

提供中西醫結合醫學的新聞及評論，從政策、研究到個人健康，包括會議、全球計畫和專業協會的最新動態。

How we started? Acknowledgement 我們是如何開始的？ 致謝

In early 2020, we started with a review on possible treatment for Covid19.

2020 年初，我們開始檢視 Covid19 的可能治療方法。

PDF File

We hope to work with the population to understand the pandemic, to help each other with information collected here and to get appropriate treatment via Telemedicine cum philanthropy projects.

The vision, mission and acknowledgement in 2020 is archived for records.

我們希望與不同人合作，了解這場流行病，利用此處收集的資訊互相幫助，並透過遠距醫療暨慈善計畫獲得適當的治療。 2020年的願景、使命和致謝已存檔。

背景

  1.  由於疫症於全球大爆發，世界各地不可避免將有輸入/本土個案形成的繼發高峰。
  2.  現時用作遏止及緩和疫情的措施並不足。
  3.  有證據顯示中藥可預防及減輕病情。
  4. 迫切需要利用中醫視像診症以減少感染數字、嚴重個案及死亡，亦可避免醫院的前線工作負荷過重及崩潰。
  5.  鑑於約有幾成感染個案均無症狀，中醫藥的治未病概念可減少更多隱形病人。

目的

  1.  以科學與專家意見為本建立可靠性高的網上資訊與臨床諮詢平台。
  2.  為市民提供網上“治未病”服務，以減少社交接觸，及支援各類檢疫隔離人群。
  3.  為高危及貧困市民「贈醫施藥」。
  4. 促進三方(大學、慈善機構及商界)合作，服務社會，推動科研，提高中醫藥在本地及全球的地位。

Background

  1.  With the raging pandemic, local and imported cases may produce recurrent and sustained epidemic peaks in different parts of the world.
  2.  Containment and mitigation measures are not good enough to prevent transmission.
  3. There is evidence that Chinese Medicine may prevent the disease and reduce severity.
  4. There is an urgent need to use telemedicine to- Reduce infection numbers- Reduce severity & death- Prevent overload & collapse of hospitals
  5. Since substantial number of COVID-19 infection is asymptomatic, the “治未病” concept of Chinese medicine would help to decrease this pool of hidden patients.

Purpose

  1. To build a reliable information and clinical service portal based on scientific and/or expert advice, targeting influenza in general, and COVID-19 in particular.
  2. To serve the community in providing telemedicine consultation when there is a need for social distancing and “quarantine”.
  3. To help the needy and high risk population by providing free consultation and free medication for needy patients.
  4. To facilitate tripartite collaboration of academics, charity organization and commercial sector to serve our community, conduct research, and enhance the position of Chinese medicine locally and globally.

Acknowledgement

  • Beijing Tong Ren Tang Hong Kong Medicine Management Ltd.
  • Hong Kong Chinese Medicine Pharmacists Association
  • Hong Kong Pharmaceutical Care Foundation
  • Hong Kong SKH Lady MacLehose Centre
  • Institute of Healthcare Management of The Hong Kong Management Association
  • Joseph Needham Foundation for Science & Civilization (Hong Kong)
  • School of Chinese Medicine, University of Hong Kong
  • Research team of Chinese medicinal pharmacy, Technological and Higher Education Institute of Hong Kong
  • All volunteer Chinese Medicine Practitioners,
  • All Information Education Communication (IEC) advisers and editors,
  • Dr Wilson Fung for telemedicine application development,
  • Mr Gabriel Yu for generous donation and encouragement,
  • Hon Prof Vivian Taam Wong for conception, donation and execution.

免責聲明

  1. 本網站所提供的健康資訊及資源乃供參考之用，並不能取代醫生的專業意見、診斷、或治理、以及未必適用於任何情況。如對身體狀況有任何疑問，謹記向合資格的醫生求助。
  2. 另外， 部份的健康資訊源自其他第三者營運之機構或網站。本網站盡力審核所提供資訊的準確性，惟仍會存在資訊失誤或過時的可能性。本網站並不對上述資訊作出任何承擔或認可。重申資訊乃供參考之用， 及謹記向合資格的醫生求助。

Collectors 搜集人

  • Vivian Taam Wong, JP 黃譚智媛

Hon Fellow of the University of Hong Kong & Hong Kong Metropolitan University

MBBS, FRCOG, FFPH, FRCP(London), FRACMA, FHKAM, FHKIoD

Hon Professor, School of Chinese Medicine, the University of Hong Kong

Hon Professor, the Hong Kong Polytechnic University

Former Adjunct Professor, The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, the Chinese University of Hong Kong

CM Related Positions:

  • Hon President, HK Association for Integration of Chinese-Western Medicine
  • Former Executive Board Member, Chinese Association of Integrative Medicine
  • Former Board Member, China Association for Acupuncture and Moxibustion
  • Member, International Clinical Standards of Traditional Chinese Medicine Committee,      World Federation of Chinese Medicine Societies (WFCMS)
  • Member, New Drug Discovery in Traditional Chinese Medicine and Natural Medicine Committee, WFCMS
  • Executive Member, Anti-aging Committee, WFCMS
  • Vice President, Modernized Chinese Medicine International Association
  • Board of Director, GP-TCM Research Association
  • HK Coordinator, Consortium for Globalization of Chinese Medicine
  • Member, Advisory Committee, School of Chinese Medicine, HK Baptist University

Key Past Appointments:

  • Research Fellow, Medical Unit, Royal Free Hospital Medical School, London
  • Public Health Specialist, Policy & Research, Population Health & Nutrition, The World Bank
  • Reader in Obstetrics & Gynaecology, the University of  Hong Kong
  • Hospital Chief Executive, Queen Mary Hospital, Hong Kong
  • Director, Professional Services & Medical Development; Director, Strategy & Planning;            Chief Executive, Hospital Authority, Hong Kong
  • Hon Advisor in Integrative Medicine, Hospital Authority, Hong Kong
  • Hon Senior Advisor to Dean of Medical Faculty, the University of Hong Kong

Past Service to International Organizations:

  • Secretary, Panel on Steroidal Contraceptives, International Planned Parenthood Federation
  • Chairman, Committee on Safe Motherhood, International Federation of Gynaecology & Obstetrics
  • Member, International Committee, International Society for Study of Hypertension in Pregnancy
  • Member, Scientific Council, International Association for Maternal & Neonatal Health
  • Member of Committees under World Health Organization (Maternal Health Research, MCH/FP in Primary Health Care, RCT for Evaluation of New Antenatal Care Model)
  • Senior Advisor, GP-TCM in the post genomic era (EU FP7)

Key Past Professional Service in HK

  • President, The Obstetrical and Gynaecological Society of Hong Kong
  • President, Hong Kong Association for Maternal and Neonatal Health
  • Junior Vice President, The Hong Kong College of Obstetricians and Gynaecologists
  • Trustee, Hong Kong Obstetrical & Gynaecological Trust Fund
  • Vice Chairman, UNICEF Baby Friendly Hospital Initiative Hong Kong Association

With wide research interest from perinatology, haematology, hepatology to Chinese Medicine, her initial first-authored papers appeared in New England Journal of Medicine in 1978 and Lancet in 1984.  She has been on editorial boards of 6 journals, and has published >130 peer-reviewed papers, and co-edited the book “Challenges of SARS”.  She was responsible for setting up the unique Hong Kong-wide Research Ethics Committee system and standards enabling multicentre trials.  The high quality network of Chinese Medicine Centre for Training and Research in each districts in Hong Kong was established under her leadership. She is now steering education, research and knowledge transfer to support collaboration among CM and western medicine practitioners.

黃譚智媛教授現為香港大學中醫藥學院名譽教授、香港理工大學名譽教授、香港中西醫結合醫學會榮譽會長、世中聯國際中醫藥臨床標準工作委員會委員、世中聯抗衰老專業委員會常務理事、世中聯中藥新藥創制專業委員會理事、現代化中醫藥國際協會副會長、中醫藥規範研究學會董事、中藥全球化聯盟香港區統籌。

黃譚教授於婦產科、內科及公共衛生三個範疇均擁有院士資歷，並獲香港大學、香港都會大學授予榮譽院士。她長期投身醫學教育、研究及改善公共衛生，曾任世界銀行公共衞生專家、統籌中國「農村醫療人材培訓」，香港醫院管理局行政總裁，瑪麗醫院行政總監，香港大學婦產科教授，曾任公職中國中西醫結合醫學會常務理事，中國針灸學會理事，國際婦產科聯盟妊娠安全委員會主席，以及世界衞生組織多項計畫專家顧問，香港婦產科學會主席，香港孕產婦和新生兒健康學會主席，聯合國兒童基金會愛嬰醫院香港協會副主席，香港「地球之友」主席，港中文大學中醫藥學院及公共衞生學院特邀教授，香港浸會大學中醫藥學院諮詢委員會委員及特邀教授。

黃譚智媛教授積極投身公共及社會服務，範疇遍及婦女、兒童、環保、教育、健康及中醫藥，並在香港、中國內地和國際領域擔當領導角色，現積極協助各界人士合力為中醫藥業界創造國際發展機會。於1999年，獲香港特別行政區政府頒授太平紳士（J.P.）。

  • Thomas H Cheng 鄭浩

BMed, MCM, Certificates of Old & New Testament Studies and Theological & Historical Studies

中西醫結合醫學學士，中醫學碩士，舊新約、神學及歷史證書

  • Chong Man Nga 莊雯雅

B.Sc (Chinese Medicinal Pharmacy)(Honours)

中藥藥劑學（榮譽）理學士

We are not responsible for the contents which come from respective authors, publishers, and organizations.

我們對來自各作者、出版商和組織的內容不承擔任何責任。